MarkACreagerMD

Cardiology • Lebanon, NH

Vascular Medicine

Director, Heart and Vascular Center, Dartmouth-Hitchcock, Professor of Medicine, Geisel School of Medicine at Dartmouth

Join to view full profile

Dr. Creager is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Creager's full profile

Already have an account?

Office
1 Medical Center Dr
Lebanon, NH 03756
Phone+1 603-650-8283

Education & Training

Boston University Medical CenterFellowship, Cardiovascular Disease, 1977 - 1979
Boston University Medical CenterResidency, Internal Medicine, 1974 - 1977
Lewis Katz School of Medicine at Temple UniversityClass of 1974

Certifications & Licensure

MA State Medical License 1976 - 2025
NH State Medical License 2015 - 2025
VT State Medical License 1988 - 2024
RI State Medical License 2011 - 2014
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Elected Member The American Society for Clinical Investigation, 1993
Fellow (FACC) American College of Cardiology

Clinical Trials

The Effect of Fasudil on Vascular Function in Humans Start of enrollment: 2002 Jun 01
Completed
Phase 2
ARREST PAD (Peripheral Arterial Disease) Start of enrollment: 2004 Jan 01
Completed
Phase 2, Phase 3
Free Fatty Acids and Vascular Function in Subjects With Diabetes Start of enrollment: 2005 Sep 01
Completed
Phase 1, Phase 2
Ventricular-Vascular Coupling in Heart Failure Start of enrollment: 2004 Jan 01
Completed
Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information Start of enrollment: 2007 Jan 01
Completed
Not Applicable
Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk Start of enrollment: 2007 Sep 01
Unknown status
Rho Kinase (ROCK) Inhibition in Carotid Atherosclerosis Start of enrollment: 2008 Mar 13
Terminated
Phase 2
A Randomized Clinical Trial To Study Losartan On Endothelial Dysfunction and Insulin Resistance In Obese Patients Start of enrollment: 2007 May 01
Completed
Phase 4
Effects of Losartan Versus Atenolol on Aortic and Cardiac Muscle Stiffness in Adults With Marfan Syndrome Start of enrollment: 2007 Oct 01
Completed
Phase 3
The Role of Endothelin in Pulmonary Hypertension Start of enrollment: 1999 Feb 01
Completed
Phase 2
Signaling Mechanisms and Vascular Function in Diabetes Mellitus Start of enrollment: 1999 May 01
Completed
Phase 2, Phase 3
Signaling Mechanisms and Vascular Function in Patients With Diabetes Mellitus Start of enrollment: 1999 May 01
Completed
Phase 2, Phase 3
Gestational Diabetes Mellitus and Cardiovascular Disease: The Role of Vascular Dysfunction Start of enrollment: 2009 Aug 01
Unknown status
Relaxation Response Training to Treat Hypertension Start of enrollment: 2009 Apr 01
Completed
Not Applicable
Metformin, Muscle Energetics, and Vascular Function in Older Adults With Peripheral Artery Disease Start of enrollment: 2013 Jul 01
Terminated
Phase 4
Join now to see all

Publications & Presentations

PubMed

28 citations
Venous Thromboembolism Associated With Pregnancy: JACC Focus Seminar.
Katherine M. Nichols, Stanislav Henkin, Mark A. Creager
Journal of the American College of Cardiology. 2020-11-03
54 citations
Metabolic Syndrome, Inflammation, and Risk of Symptomatic Peripheral Artery Disease in Women A Prospective Study
David Conen, Kathryn M. Rexrode, Mark A. Creager, Paul M. Ridker, Aruna D. Pradhan
Circulation. 2009-09-22
1331 citations
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update A Guideline From the Americ...
Sidney C. Smith, Emelia J. Benjamin, Robert O. Bonow, Lynne T. Braun, Mark A. Creager
Circulation. 2011-11-29

Journal Articles

Pathology of Arterial Disease in Limb Loss
Mark A Creager, Marc P Bonaca, ScienceDirect

Lectures

A Bon VOYAGER for Peripheral Artery Disease
American Heart Association, New Orleans, Louisiana - 3/19/2013

Authored Content

A Bon VOYAGER for Peripheral Artery DiseaseMay 2020
Antithrombotic Therapy for Peripheral Artery Disease Recent AdvancesMay 2018

Press Mentions

Food Insecurity Linked to Increased Heart Risks for People with Peripheral Artery DiseaseOctober 31st, 2022
Smoking Drives Postprocedure Complication Rate in PAD RevascularizationOctober 8th, 2021
New Advanced Training Outlined for Future Vascular Medicine SpecialistsJanuary 21st, 2021
Join now to see all

Grant Support

Clinical And Research Training Program For Academic Vascular Medicine SpecialistsNational Heart, Lung, And Blood Institute2007–2011
Targeting Inflammation To Improve Endothelial Function In Type 2 Diabetes: A SubsNational Heart, Lung, And Blood Institute2008–2010
Mechanisms Of Arterial Dysfunction In Type 2 Diabetes MellitusNational Heart, Lung, And Blood Institute2005–2009
The Contribution Of Inflammation And Insulin ResistanceNational Center For Research Resources2006–2008
Signaling Mechanisms And Vascular Function In Diabetes MellitusNational Center For Research Resources2005–2008
Inflammation And Insulin Resistance In PADNational Heart, Lung, And Blood Institute2003–2007
Clinical Research Training Program For Academic VascularNational Heart, Lung, And Blood Institute2006
Impact Of Free Fatty Acid Reduction On Vascular Function And Skeletal MuscleNational Center For Research Resources2006
The Effects Of Fasudil On Vascular Function In HumansNational Center For Research Resources2005–2006
The Contribution Of Inflammation And Insulin ResistanceNational Center For Research Resources2005
Signaling Mechanisms /Vascular Function In Diabetes MellNational Center For Research Resources2004
Effects Of Fasudil On Vascular Function In HumansNational Center For Research Resources2004
Coa Reductase Inhibitors And Vascular FunctionNational Center For Research Resources2004
Neurohormonal Control Of Vascular Function In Heart FailureNational Center For Research Resources2000–2002
Mechanisms Of Arterial Dysfunction In Diabetes MellitusNational Heart, Lung, And Blood Institute1992–2002
Antioxidants And Endothelial Function In DiabetesNational Heart, Lung, And Blood Institute1997–2000
Phase II Study Of Fiblast Trafermin In Treatment Of Intermittent ClaudicationNational Center For Research Resources1998–1999
Effect Of Angiotensin II On Human Endothelial FunctionNational Center For Research Resources1997–1999
Estrogen And Vascular Function In Postmenopausal WomenNational Center For Research Resources1996–1999
Vascular Disease Academic AwardNational Heart, Lung, And Blood Institute1991–1995
Mechanisms Of Vascular Dysfunction In Diabetic HumanNational Center For Research Resources1994
Effects Of Sodium On Baroreflex Function In ManNational Center For Research Resources1989–1994
Effect Of Sodium On Baroreflex Function In ManNational Heart, Lung, And Blood Institute1987–1991
Sodium'S Effect On Baroreflex Function In ManNational Heart, Lung, And Blood Institute1987–1989